| Primary |
| Upper Respiratory Tract Infection |
66.7% |
| Atrial Fibrillation |
33.3% |
|
| Abdominal Wall Haematoma |
100.0% |
|
| Secondary |
| Back Pain |
30.8% |
| Product Used For Unknown Indication |
16.7% |
| Drug Use For Unknown Indication |
6.6% |
| Hypertension |
5.7% |
| Chest Pain |
4.4% |
| Hepatitis C |
4.4% |
| Neuralgia |
4.4% |
| Headache |
3.5% |
| Polyarthritis |
3.5% |
| Arthralgia |
3.1% |
| Osteoarthritis |
2.2% |
| Suicidal Ideation |
2.2% |
| Angina Pectoris |
1.8% |
| Epilepsy |
1.8% |
| Essential Hypertension |
1.8% |
| Herpes Zoster Ophthalmic |
1.8% |
| Myalgia |
1.8% |
| Renal Colic |
1.8% |
| Anticoagulant Therapy |
0.9% |
| Cardiac Failure |
0.9% |
|
| Melaena |
10.2% |
| Renal Failure Acute |
10.2% |
| Retroperitoneal Fibrosis |
10.2% |
| Death |
8.2% |
| Gastric Ulcer |
6.1% |
| Hypertransaminasaemia |
6.1% |
| Urticaria |
6.1% |
| Vomiting |
6.1% |
| Gastric Ulcer Haemorrhage |
4.1% |
| Hypertension |
4.1% |
| Oesophagitis |
4.1% |
| Suicide Attempt |
4.1% |
| Syncope |
4.1% |
| Upper Respiratory Tract Infection |
4.1% |
| Abdominal Pain Upper |
2.0% |
| Acute Hepatic Failure |
2.0% |
| Aspartate Aminotransferase Increased |
2.0% |
| Drug-induced Liver Injury |
2.0% |
| Dyspepsia |
2.0% |
| Erythema |
2.0% |
|
| Concomitant |
| Rheumatoid Arthritis |
23.0% |
| Product Used For Unknown Indication |
13.0% |
| Breast Cancer |
8.1% |
| Drug Use For Unknown Indication |
6.7% |
| Pain |
6.7% |
| Osteoporosis |
5.9% |
| Osteoarthritis |
4.4% |
| Prophylaxis |
4.4% |
| Arthralgia |
3.0% |
| Depression |
3.0% |
| Hypertension |
3.0% |
| Hypothyroidism |
2.6% |
| Analgesic Therapy |
2.2% |
| Cough |
2.2% |
| Fibromyalgia |
2.2% |
| Hyponatraemia |
2.2% |
| Prophylaxis Against Gastrointestinal Ulcer |
2.2% |
| Osteoporosis Prophylaxis |
1.9% |
| Toothache |
1.9% |
| Breast Cancer Metastatic |
1.5% |
|
| Neutropenia |
10.5% |
| Joint Prosthesis User |
8.8% |
| Osteonecrosis |
7.0% |
| Pancreatitis Acute |
7.0% |
| Cellulitis |
5.3% |
| Injection Site Erythema |
5.3% |
| Miller Fisher Syndrome |
5.3% |
| Myocardial Infarction |
5.3% |
| Pruritus |
5.3% |
| Urticaria |
5.3% |
| Bronchopneumonia |
3.5% |
| Dyspnoea |
3.5% |
| Herpes Zoster |
3.5% |
| Liver Function Test Abnormal |
3.5% |
| Paraesthesia |
3.5% |
| Polyneuropathy |
3.5% |
| Renal Failure |
3.5% |
| Sensorimotor Disorder |
3.5% |
| Sopor |
3.5% |
| Vertigo |
3.5% |
|
| Interacting |
|
| Hepatic Necrosis |
50.0% |
| Liver Disorder |
50.0% |
|
